Package 0615-8262-39

Brand: bupropion

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0615-8262-39
Digits Only 0615826239
Product NDC 0615-8262
Product ID 0615-8262_f36c7e1c-d5b0-4d3d-bf68-1e90b113fca4
Description

30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8262-39)

Marketing

Marketing Status
Discontinued 2026-02-28
Brand bupropion
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

bupropion ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f36c7e1c-d5b0-4d3d-bf68-1e90b113fca4", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["c5a0636b-229e-45ae-8f2c-50bb21f56d25"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8262-39)", "package_ndc": "0615-8262-39", "marketing_end_date": "20260228", "marketing_start_date": "20190108"}], "brand_name": "bupropion", "product_id": "0615-8262_f36c7e1c-d5b0-4d3d-bf68-1e90b113fca4", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0615-8262", "generic_name": "bupropion hydrochloride", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA202304", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20141101"}